This content is for ESMO members only.

Login

Learn more about how you can join ESMO

Presentation

Download slides

Programme

5 June 2024

Welcome and introduction

Nadia Harbeck

Screening for breast cancer – what can we do beyond mammography

Tanja Gagliardi

Lifestyle changes – is prevention possible?

Suzette Delaloge

Emerging data on: How to deal with hereditary risk

Shani Paluch-Shimon

LIVE Discussion and Q&A

All

Nadia Harbeck
Chair

LMU University Hospital, Munich
Tanja Gagliardi
Speaker

Royal Marsden Hospital
Suzette Delaloge
Speaker

Gustave Roussy, Villejuif
Shani Paluch-Shimon
Speaker

Hadassah University Hospital

Description

This ESMO Deep Dive Breast Cancer Webinar focusd on breakthroughs in personalised, molecularly informed risk prediction, screening and early detection in breast cancer.

This webinar was developed with the aim to provide a second, deeper layer of educational experience in emerging data related to: molecular biology and classification, translational research and biomarkers for precision medicine, and unknowns, hypotheses, and ongoing research in areas of controversy or unmet need for optimal management of patients.

It began with a brief welcome and introduction, then a lecture on screening options beyond mammography. This was followed by a talk on lifestyle changes and prevention, and lastly, by a discussion of the emerging data on dealing with hereditary risks. The lectures were followed by a live discussion with the speakers’ panel.

This programme was designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with breast cancers, offer expert opinion exchange, and provide some important considerations in this field.

Learning objectives

To acquire a deeper understanding of the clinical course of malignant disease of breast cancer.
To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for breast cancer.
To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies.
To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects.